Advancing towards Ubiquitous EEG, Correlation of In-Ear EEG with Forehead EEG.

BCI biopotential electrodes correlation forehead EEG impedance spectroscopy in-ear EEG

Journal

Sensors (Basel, Switzerland)
ISSN: 1424-8220
Titre abrégé: Sensors (Basel)
Pays: Switzerland
ID NLM: 101204366

Informations de publication

Date de publication:
17 Feb 2022
Historique:
received: 30 10 2021
revised: 09 01 2022
accepted: 14 02 2022
entrez: 26 2 2022
pubmed: 27 2 2022
medline: 3 3 2022
Statut: epublish

Résumé

Wearable EEG has gained popularity in recent years driven by promising uses outside of clinics and research. The ubiquitous application of continuous EEG requires unobtrusive form-factors that are easily acceptable by the end-users. In this progression, wearable EEG systems have been moving from full scalp to forehead and recently to the ear. The aim of this study is to demonstrate that emerging ear-EEG provides similar impedance and signal properties as established forehead EEG. EEG data using eyes-open and closed alpha paradigm were acquired from ten healthy subjects using generic earpieces fitted with three custom-made electrodes and a forehead electrode (at Fpx) after impedance analysis. Inter-subject variability in in-ear electrode impedance ranged from 20 kΩ to 25 kΩ at 10 Hz. Signal quality was comparable with an SNR of 6 for in-ear and 8 for forehead electrodes. Alpha attenuation was significant during the eyes-open condition in all in-ear electrodes, and it followed the structure of power spectral density plots of forehead electrodes, with the Pearson correlation coefficient of 0.92 between in-ear locations ELE (Left Ear Superior) and ERE (Right Ear Superior) and forehead locations, Fp1 and Fp2, respectively. The results indicate that in-ear EEG is an unobtrusive alternative in terms of impedance, signal properties and information content to established forehead EEG.

Identifiants

pubmed: 35214468
pii: s22041568
doi: 10.3390/s22041568
pmc: PMC8879675
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Int J Psychophysiol. 2012 Oct;86(1):1-24
pubmed: 22820267
Int J Psychophysiol. 1996 Nov;24(1-2):161-71
pubmed: 8978441
Sleep Sci. 2016 Apr-Jun;9(2):69-72
pubmed: 27656268
Clin Neurophysiol. 2007 Dec;118(12):2765-73
pubmed: 17911042
Biol Cybern. 2005 Mar;92(3):177-85
pubmed: 15739111
Proc Natl Acad Sci U S A. 2019 Nov 19;116(47):23772-23782
pubmed: 31685634
Brain Res Brain Res Rev. 1999 Apr;29(2-3):169-95
pubmed: 10209231
Neurology. 2020 Oct 20;95(16):e2259-e2270
pubmed: 32764101
IEEE Trans Biomed Eng. 2019 Jan;66(1):150-158
pubmed: 29993415
Annu Int Conf IEEE Eng Med Biol Soc. 2015;2015:3161-4
pubmed: 26736963
Sci Rep. 2015 Nov 17;5:16743
pubmed: 26572314
Front Neurosci. 2015 Nov 18;9:438
pubmed: 26635514
Annu Int Conf IEEE Eng Med Biol Soc. 2016 Aug;2016:5709-5712
pubmed: 28269551
J Altern Complement Med. 2009 Nov;15(11):1187-92
pubmed: 19922249
IEEE Trans Biomed Eng. 2013 Oct;60(10):2824-30
pubmed: 23722447
Sci Rep. 2019 Nov 14;9(1):16824
pubmed: 31727953
Annu Int Conf IEEE Eng Med Biol Soc. 2011;2011:6882-5
pubmed: 22255920
Front Psychol. 2011 Jul 05;2:154
pubmed: 21779269
Annu Int Conf IEEE Eng Med Biol Soc. 2015;2015:2271-4
pubmed: 26736745
J Invest Dermatol. 1977 Sep;69(3):324-7
pubmed: 894073
Front Neuroinform. 2018 Dec 10;12:95
pubmed: 30618700
Physiol Meas. 2010 Oct;31(10):S183-98
pubmed: 20834109

Auteurs

Swati Mandekar (S)

Institute for Bioengineering, University of Applied Sciences Aachen, 52005 Aachen, Germany.
IDUN Technologies AG, Alpenstrasse 3, 8152 Glattpark, Switzerland.

Abigail Holland (A)

IDUN Technologies AG, Alpenstrasse 3, 8152 Glattpark, Switzerland.

Moritz Thielen (M)

IDUN Technologies AG, Alpenstrasse 3, 8152 Glattpark, Switzerland.

Mehdi Behbahani (M)

Institute for Bioengineering, University of Applied Sciences Aachen, 52005 Aachen, Germany.

Mark Melnykowycz (M)

IDUN Technologies AG, Alpenstrasse 3, 8152 Glattpark, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH